 Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati
Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati Firstsource and Monash University Sign Strategic MoU
Firstsource and Monash University Sign Strategic MoU Deep Diamond India Limited declares interim dividend of Rs. 0.10
Deep Diamond India Limited declares interim dividend of Rs. 0.10 Steelcast Ltd declares 2nd interim dividend of Rs. 0.36
Steelcast Ltd declares 2nd interim dividend of Rs. 0.36 Lancor Holdings Ltd gets favorable verdict from SC in commercial property case
Lancor Holdings Ltd gets favorable verdict from SC in commercial property case 
              Ashok Leyland's (AL) Q1FY11 results were below our estimate as the company disappointed on the realisations front. With a 3.7% sequential drop in realisations, revenues were at Rs23.5bn as against our estimate of Rs25bn. In addition, higher employee expenses resulted in a 285bps QoQ drop in margins. Due to this net profits at Rs1.2bn were 14% below our estimates.
Outlook: We expect AL to clock volumes of 80k units in FY11 and 88k units in FY12. The company has guided for a volume of 85k units in FY11. Despite the lower margins of Q1FY11, we maintain our margin estimates for FY11 at 11.5%. We maintain our earnings estimates for FY11 and FY12 at Rs4.5 and Rs5.1 respectively.
VALUATIONS AND RECOMMENDATION
The stock is currently trading at 14x FY12E earnings and 9.2x FY12E EV/EBITDA. At the current valuations, we find the company to be fairly valued. Hence, we downgrade the stock to 'HOLD' while maintaining our price target of Rs67, discounting FY12E earnings 13x.